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Résumé en
anglais
BACKGROUND: Diminished ovarian reserve (DOR) is one of the causes of infertility
in young women. In this prospective study, gene expression profiling (GEP) of corona
radiata cells (CRC) was performed to identify genes deregulated in DOR patients.
METHODS: Microarray-based GEP of CRC isolated from eight women undergoing
IVF was performed to identify genes differentially expressed between patients with
normal ovarian reserve and DOR patients. Microfluidic-based quantitative RT-PCR
assays were used to validate selected transcripts on 40 independent patients. A
principal component analysis was used to identify more homogeneous subgroups of
DOR patients. In silico analyses focusing on cis-regulation were performed to refine
the interactions between patient's biological characteristics and their GEP.
RESULTS: Forty-eight transcripts were differentially expressed, including CXXC
finger protein 5 (CXXC5), forkhead box C1 (FOXC1) (down-regulated in DOR) as well
as connective tissue growth factor (CTGF), follistatin-like 3 (FSTL3), prostaglandin-
endoperoxide synthase 2 (PTGS2) and suppressor of cytokine signaling 2 (SOCS2)
(up-regulated in DOR). According to these transcripts, two DOR patients' subgroups
(DOR Gr1 and Gr2) were identified. In DOR Gr2 patients, C-terminal domain 2
(CITED2), CTGF, growth arrest-specific 1 (GAS1), insulin receptor substrate 2
(IRS2), PTGS2, SOCS2 and Versican (VCAN) were expressed at significantly higher
levels and CXXC5, FOXC1, guanylate-binding protein 2 (GBP2) and zinc finger MIZ-
domain containing 1 (ZMIZ1) at significantly lower levels. Higher baseline estradiol
(E(2)) levels were observed in DOR Gr2 patients (P < 0.006). The in silico analyses
suggested that all 11 genes differentially expressed between DOR Gr1 and DOR Gr2
subgroups could be transcriptional targets of estrogen. CONCLUSIONS: Despite
small sample size limitations, 12 genes deregulated in the CRC of DOR patients were
identified, which could be involved in DOR pathogenesis. A DOR patient's subgroup
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